Waters
WAT | NYSE
$453.42
-$6.83 (-1.48%)
At close: Nov 16, 2026, 4:00 PM ET
$455.20
+$1.78 (+0.39%)
After-hours:
Nov 16, 2026, 4:11 PM ET
Waters Company Profile
Company profile explainedCompany Profile
Waters Corporation is a global leader in specialized measurement, delivering analytical solutions across Asia, the Americas, and Europe. The company operates through two main divisions: Waters and TA. Under its Waters segment, it engineers, manufactures, sells, and provides support for high and ultra-performance liquid chromatography and mass spectrometry (MS) systems. This includes essential consumables like chromatography columns and comprehensive post-warranty service plans. The TA segment focuses on designing, producing, selling, and servicing instruments for thermal analysis, rheometry, and calorimetry. Additionally, Waters develops and supplies sophisticated software that integrates with both its own instruments and those from other manufacturers. The company's advanced MS technology plays a crucial role in various applications, such as drug discovery and development (including clinical trial assessments), analyzing proteins involved in disease processes, ensuring nutritional safety, and conducting environmental testing. Its thermal analysis, rheometry, and calorimetry instruments are vital for assessing the suitability and stability of a wide range of materials, including fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids. These instruments support diverse sectors like industrial manufacturing, consumer goods, healthcare products, and life science research. Waters' extensive client base spans the life sciences, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental sectors, where its products are instrumental in research and development, quality assurance, and general laboratory operations. Established in 1958, Waters Corporation is headquartered in Milford, Massachusetts.
Key Executives
| Name | Position |
|---|---|
| Udit Batra | President, Chief Executive Officer & Director |
| Amol Chaubal | Senior Vice President & Chief Financial Officer |
| Brook Colangelo | Senior VP & Chief Information Officer |
| Allan Jaenicke | Senior Vice President of Transformation |
| Caspar Tudor | Head of Investor Relations |
| Christos Ross | Senior Vice President of Global Operations |
| Daniel Rush | Senior Vice President of Global Research & Strategy |
| Jianqing Y. Bennett | Senior Vice President of Waters Advanced Diagnostics Division |
| Keeley A. Aleman | Senior VP, General Counsel, Head of Global Human Resources & Corporate Secretary |
| Kristen Garvey | Senior Vice President of Global Communications |
| Mark Gladwell | Senior Vice President of Global Operations |
| Steve Conly | Senior Vice President of Waters Biosciences Division |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 02, 2026 | 4 | Filing |
| Oct 02, 2026 | 4 | Filing |
| Aug 31, 2026 | 3 | Filing |
| Aug 21, 2026 | 8-K | Current Report |
| Aug 11, 2026 | 10-Q | Quarterly Report |
| Aug 07, 2026 | 4 | Filing |
| Aug 04, 2026 | 8-K | Current Report |
| Jul 02, 2026 | 4 | Filing |
| Jul 02, 2026 | 4 | Filing |
| Jun 25, 2026 | 4 | Filing |
Waters
| Country | United States |
| IPO Date | Nov 17, 1995 |
| Industry | Medical - Diagnostics & Research |
| Sector | Healthcare |
| Employees | 7,900 |
| CEO | Udit Batra |
Contact Details
34 Maple Street Milford,
Massachusetts 01757 United States
Stock Details
| Ticker Symbol | WAT |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001000697 |
| CUSIP Number | 941848103 |
| ISIN Number | US9418481035 |
| SIC Code | 3826 |
Recent News
- 5 days ago / zacks.comWaters Gains FDA Clearance for Flow Cytometry Tests for Blood Cancers
- 6 days ago / prnewswire.comWaters Achieves FDA 510(k) Clearance for Ready-to-Use Flow Cytometry Clinical Tests for Leukemia and Lymphoma
- 8 days ago / zacks.comWaters Expands Proteomics Reach With MOBILion Systems Acquisition
- 13 days ago / marketbeat.comWaters Q3 Earnings Call Highlights
- 14 days ago / zacks.comWaters Q3 Earnings & Revenues Beat Estimates, 2026 Guidance Raised
- 14 days ago / seekingalpha.comWaters Corporation (WAT) Q3 2026 Earnings Call Transcript
- 14 days ago / zacks.comWaters (WAT) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
- 14 days ago / zacks.comWaters (WAT) Beats Q3 Earnings and Revenue Estimates
- 14 days ago / prnewswire.comWaters Corporation (NYSE: WAT) Reports Third Quarter 2026 Financial Results
- 14 days ago / prnewswire.comWaters Acquires MOBILion Systems, Bringing Advanced Ion-Mobility Separation to its Mass Spectrometry Portfolio with the Speed and Resolution AI Workflows Require for Proteomics Biomarker Discovery
Add to Watchlist
Select watchlists to add or remove WAT